Telogen Effluvium
What is Telogen Effluvium
Telogen effluvium is a temporary but often alarming form of hair shedding that occurs when a significant number of hair follicles prematurely shift from the growth phase into the resting phase of the hair cycle. Under normal conditions, approximately 85–90 percent of scalp hairs remain in active growth, while a small percentage are in a resting phase and shed naturally. In telogen effluvium, this balance is disrupted, leading to excessive shedding of scalp hair. Unlike patterned or autoimmune hair loss, telogen effluvium typically does not produce well-defined bald patches. Instead, individuals experience diffuse thinning and increased daily hair fall, often noticing large amounts of hair in the shower, on pillows, or during brushing. Because the follicles remain intact, regrowth is usually possible once the triggering factor is addressed. This condition often begins 2 to 3 months after a physical or emotional stressor, making it difficult to connect the shedding to its underlying cause immediately.
What Are the Causes
Telogen effluvium is most commonly triggered by a physiological or emotional stress event that disrupts the normal hair growth cycle. Common triggers include significant illness, surgery, high fever, childbirth, rapid weight loss, severe emotional stress, or major life changes.
Hormonal fluctuations are a frequent contributor. Postpartum hair shedding is one of the most well-known examples, occurring as estrogen levels decline after delivery. Thyroid disorders, nutritional deficiencies (such as low iron or vitamin D), and sudden dietary changes can also prematurely shift follicles into the resting phase.
Certain medications, including those that affect blood pressure, mood, or hormone regulation, may contribute to shedding. Infections, inflammatory illnesses, and chronic systemic conditions can further impact follicular cycling.
While genetics does not directly cause telogen effluvium, individuals with underlying androgenetic alopecia may experience more pronounced thinning during shedding episodes.
Symptoms
The hallmark symptom of telogen effluvium is excessive diffuse shedding across the entire scalp. Hair loss is typically noticeable during washing or brushing, with individuals noticing more strands than usual.
Unlike alopecia areata or traction alopecia, there are no distinct patches or areas of scarring. The hairline generally remains intact. Density may gradually decrease, particularly if shedding persists for several months.
Some individuals report scalp sensitivity or mild discomfort, although visible inflammation is uncommon. The scalp itself appears normal without redness, scaling, or scarring.
In acute cases, shedding may last three to six months before gradually stabilizing. In chronic telogen effluvium, shedding may persist for more than 6 months, often fluctuating in intensity.
How Many People Are Affected
Telogen effluvium is one of the most common causes of sudden hair shedding worldwide. It affects both men and women, but is more frequently reported in women due to hormonal changes and postpartum shedding.
It can occur at any age but is most commonly observed in adults following a significant physical or emotional stressor. Because many triggers are temporary and common—such as illness, surgery, or psychological stress—episodes of telogen effluvium are widespread.
Many individuals experience at least one episode during their lifetime, particularly during periods of physiological change or heightened stress.
Complications
Telogen effluvium does not permanently damage hair follicles, and in most cases, hair regrows once the triggering factor is resolved. However, prolonged or repeated episodes may result in visible thinning, particularly in individuals with an underlying genetic predisposition to hair loss.
Chronic shedding can create emotional distress, anxiety, and fear of permanent baldness. The psychological impact may be significant even when regrowth potential remains strong.
If the underlying trigger is not identified—such as untreated thyroid dysfunction or nutritional deficiency—shedding may continue. In some cases, telogen effluvium can unmask early androgenetic alopecia, underscoring the importance of carefully evaluating persistent thinning.
Early assessment helps distinguish temporary shedding from progressive patterned loss.
Diagnosis
Diagnosis begins with a detailed medical history to identify potential stressors occurring two to three months before the onset of shedding. A clinician evaluates shedding patterns, scalp condition, and overall density.
A hair pull test may be performed to assess active shedding. Dermoscopy can help evaluate follicular structure and rule out miniaturization patterns associated with androgenetic alopecia.
Laboratory testing may be recommended to assess iron levels, thyroid function, vitamin deficiencies, hormonal imbalances, or systemic inflammation. Identifying and correcting these factors is essential for recovery.
In most cases, telogen effluvium is diagnosed clinically without the need for biopsy, although further testing may be considered if symptoms persist or alternative diagnoses are suspected.
Treatment Options
Management of telogen effluvium focuses on identifying and addressing the underlying trigger. Once the precipitating factor is corrected, the hair cycle often gradually normalizes over several months.
Nutritional optimization, stress reduction, and hormonal stabilization may support recovery. Gentle haircare practices, minimizing heat and chemical damage, and maintaining scalp health are important during the regrowth phase.
In many instances, procedural and regenerative options may be incorporated to support follicular recovery and circulation, including PRP, Exosomes, Stem Cells, Low-Level Light Therapy, peptide-based support, microneedling, and other scalp-enhancing approaches.
While shedding episodes can be distressing, telogen effluvium is generally reversible when managed appropriately. Early evaluation provides reassurance and helps ensure that no underlying systemic issue is contributing to prolonged hair loss.